NY State Senate Bill S4743

Archive: Last Bill Status - Passed Senate

Introduced
In Committee
On Floor Calendar
- Passed Senate
- Passed Assembly
Delivered to Governor
Signed/Vetoed by Governor

Your Voice

Please enter your contact information

First Name *

Last Name *

Email Address *

A valid email address is required.

Home address search or enter your address manually *

Home address is used to determine the senate district in which you reside. Your support or opposition to this bill is then shared immediately with the senator who represents you.

Optional services from the NY State Senate:

Create an account. An account allows you to officially support or oppose key legislation, sign petitions with a single click, and follow issues, committees, and bills that matter to you. When you create an account, you agree to this platform's terms of participation.

Include a custom message for your Senator? (Optional)

Enter a message to your senator. Many New Yorkers use this to share the reasoning behind their support or opposition to the bill. Others might share a personal anecdote about how the bill would affect them or people they care about.

Leave this field blank

Actions

view actions (15)

	Assembly Actions - Lowercase Senate Actions - UPPERCASE
Jan 25, 2016	referred to health delivered to assembly passed senate ordered to third reading cal.53 committee discharged and committed to rules
Jan 06, 2016	referred to health returned to senate died in assembly
Jun 15, 2015	referred to health delivered to assembly passed senate
May 27, 2015	advanced to third reading
May 20, 2015	2nd report cal.
May 19, 2015	1st report cal.823
Apr 15, 2015	referred to health

Votes

Co-Sponsors

S4743 (ACTIVE) - Details

See Assembly Version of this Bill:: A7336
Current Committee:: Assembly Health
Law Section:: Public Health Law
Laws Affected:: Amd §3306, Pub Health L
Versions Introduced in Other Legislative Sessions:: 2017-2018: S816, A1959
2019-2020: S3006, A6942

S4743 (ACTIVE) - Summary

Designates alpha-PVP, its salts, optical isomers and salts of optical isomers, as schedule I stimulant controlled substances.

S4743 (ACTIVE) - Sponsor Memo

BILL NUMBER:S4743

TITLE OF BILL:

An act to amend the public health law, in relation to designating
alpha-PVP as a schedule I stimulant controlled substance

PURPOSE OR GENERAL IDEA OF BILL:

To prohibit the sale or distribution of any product containing
alpha-PVP, also known as Flakka, also known as gravel

SUMMARY OF SPECIFIC PROVISIONS:

Section one subdivision (f) of schedule I of section 3306 of the
public health law is amended by adding a new paragraph 25

Section two sets forth the effective date

JUSTIFICATION:

Many recent news reports have brought to light the use of a new drug
similar to bath salts and methamphetamine called Flakka or Gravel. It
is one of the newer chemicals in the synthetic or designer drug
category, made from a compound called alpha-PVP, a chemical cousin of
cathinone, the amphetamine-like drug found in bath salts. People who

use these drugs experience powerful reactions and often violent
behavior. Side effects can include: nausea, vomiting, paranoia,
hallucinations, delusions, suicidal thoughts, seizures, chest pains,
and increased blood pressure and heart rate.

In July 2011, S3322B/Chapter 130 banned the sale or distribution of
any product containing Mephedrone and MDPV which were marketed as
"bath salts." While this criminalized the sale of "bath salt" products
containing Mephedrone and MDPV, a practice of making minor alterations
to chemicals to subvert statutes that prohibit distinct chemicals made
it possible for slightly altered products to continue to be sold in
New York state. In September 2013, a new law S3469A/Chapter 341 was
signed adding more chemical compounds - the type of compounds used to
make these bath salt drugs - to the state's banned substances list.
The law imposes criminal penalties on those who sell, use and/or
possess these drugs, and also Makes it a felony to sell the substances
to a minor or on school grounds.

Drug makers and suppliers have a practice of making minor alterations
to chemicals to subvert statutes that prohibit distinct chemicals,
making it possible for slightly altered products to continue to be
sold in New York state unless new legislation is passed adding the
compound to the illegal substance schedules. Flakka, also known around
the country as "gravel" can be snorted, smoke, injected or swallowed,
or can be combined with other drugs, such as marijuana. Like cocaine
and meth, Flakka comes with a comedown, often resulting in users
returning to the drug to get rid of the negative comedown feeling,
jump-starting a cycle of use that can lead to abuse. It may alter
brain chemistry in a way that makes users require a larger and larger
dose to get the same high. At high doses, Flakka may also cause the


body to reach high temperatures which may lead to severe physical
complications like kidney damage and muscle breakdown.

Excessive use of this drug has been linked with feelings of extreme
anxiety, paranoia, and hallucinations. Most recently in Florida, there
has been an instance of a man high on Flakka kicking in a door at a
police station while in a separate instance a man impaled himself on a
police fence when he tried to scale it. Since suppliers continue to
create more drugs with slightly different properties to skirt the
definition of what is illegal, New York State needs to add Flakka or
Gravel to the illegal substances schedules.

PRIOR LEGISLATIVE HISTORY:

New Bill

FISCAL IMPLICATIONS:

None

EFFECTIVE DATE:

This act shall take effect on the ninetieth day after it shall have
become law

S4743 (ACTIVE) - Bill Text download pdf

                    S T A T E   O F   N E W   Y O R K
________________________________________________________________________

                                  4743

                       2015-2016 Regular Sessions

                            I N  S E N A T E

                             April 15, 2015
                               ___________

Introduced  by  Sen.  FUNKE  -- read twice and ordered printed, and when
  printed to be committed to the Committee on Health

AN ACT to amend the  public  health  law,  in  relation  to  designating
  alpha-PVP as a schedule I stimulant controlled substance

  THE  PEOPLE OF THE STATE OF NEW YORK, REPRESENTED IN SENATE AND ASSEM-
BLY, DO ENACT AS FOLLOWS:

  Section 1. Subdivision (f) of schedule I of section 3306 of the public
health law is amended by adding a new paragraph 25 to read as follows:
  (25) ALPHA-PVP, ITS SALTS, OPTICAL ISOMERS AND SALTS OF OPTICAL  ISOM-
ERS.
  S  2.  This  act shall take effect on the ninetieth day after it shall
have become a law.







 EXPLANATION--Matter in ITALICS (underscored) is new; matter in brackets
                      [ ] is old law to be omitted.
                                                           LBD10413-01-5

Comments

Open Legislation is a forum for New York State legislation. All comments are subject to review and community moderation is encouraged.

Comments deemed off-topic, commercial, campaign-related, self-promotional; or that contain profanity, hate or toxic speech; or that link to sites outside of the nysenate.gov domain are not permitted, and will not be published. Attempts to intimidate and silence contributors or deliberately deceive the public, including excessive or extraneous posting/posts, or coordinated activity, are prohibited and may result in the temporary or permanent banning of the user. Comment moderation is generally performed Monday through Friday. By contributing or voting you agree to the Terms of Participation and verify you are over 13.

The New York State Senate

senate Bill S4743

Sponsored By

Archive: Last Bill Status - Passed Senate

Your Voice

Actions

Votes

Jan 25, 2016 - floor Vote

Floor Vote: Jan 25, 2016

Jan 25, 2016 - Rules committee Vote

Rules Committee Vote: Jan 25, 2016

Jun 15, 2015 - floor Vote

Floor Vote: Jun 15, 2015

May 19, 2015 - Health committee Vote

Health Committee Vote: May 19, 2015

Co-Sponsors

S4743 (ACTIVE) - Details

S4743 (ACTIVE) - Summary

S4743 (ACTIVE) - Sponsor Memo

S4743 (ACTIVE) - Bill Text download pdf

Comments

senate Bill S4743

Share this bill

Sponsored By

Archive: Last Bill Status - Passed Senate

Your Voice

Actions

Votes

Jan 25, 2016 - floor Vote

Floor Vote: Jan 25, 2016

Jan 25, 2016 - Rules committee Vote

Rules Committee Vote: Jan 25, 2016

Jun 15, 2015 - floor Vote

Floor Vote: Jun 15, 2015

May 19, 2015 - Health committee Vote

Health Committee Vote: May 19, 2015

Co-Sponsors

S4743 (ACTIVE) - Details

S4743 (ACTIVE) - Summary

S4743 (ACTIVE) - Sponsor Memo

S4743 (ACTIVE) - Bill Text download pdf

Comments